Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea

Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea

Abstract Background In this study, we observe the patterns initial palliative treatment for premenopausal patients with HR-positive/HER2-negative MBC and determine if nonadherence to clinical guidelines are associated with worse clinical outcomes in terms of progression-free survival (PFS) and overa...

Full description

Bibliographic Details
Main Authors: Hee Kyung Kim, Soo-Hyeon Lee, Yu Jin Kim, Song Ee Park, Han Sang Lee, Sung Won Lim, Jang Ho Cho, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Jong Han Yu, Yeon Hee Park
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Cancer
Subjects:
Metastatic breast cancer
Hormone receptor positive
Premenopausal
Chemotherapy
Online Access:http://link.springer.com/article/10.1186/s12885-018-5258-9

Internet

http://link.springer.com/article/10.1186/s12885-018-5258-9

Similar Items